Spruce Biosciences to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
28.08.2023 - Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., ...
Source: wallstreet-online.de